SI2473172T1 - Bisfosfonat sestavki in postopki za zdravljenje srčne okvare - Google Patents

Bisfosfonat sestavki in postopki za zdravljenje srčne okvare

Info

Publication number
SI2473172T1
SI2473172T1 SI201030934T SI201030934T SI2473172T1 SI 2473172 T1 SI2473172 T1 SI 2473172T1 SI 201030934 T SI201030934 T SI 201030934T SI 201030934 T SI201030934 T SI 201030934T SI 2473172 T1 SI2473172 T1 SI 2473172T1
Authority
SI
Slovenia
Prior art keywords
methods
heart failure
treating heart
bisphosphonate compositions
bisphosphonate
Prior art date
Application number
SI201030934T
Other languages
English (en)
Inventor
Kenneth W. Lyles
Cathleen S. Colon-Emeric
Christopher M. O'connor
Richard S. Stack
Colleen Stack-D'niaye
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of SI2473172T1 publication Critical patent/SI2473172T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SI201030934T 2009-09-01 2010-09-01 Bisfosfonat sestavki in postopki za zdravljenje srčne okvare SI2473172T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23879709P 2009-09-01 2009-09-01
EP10814383.5A EP2473172B1 (en) 2009-09-01 2010-09-01 Bisphosphonate compositions and methods for treating heart failure
PCT/US2010/047417 WO2011028737A2 (en) 2009-09-01 2010-09-01 Bisphosphonate compositions and methods for treating heart failure

Publications (1)

Publication Number Publication Date
SI2473172T1 true SI2473172T1 (sl) 2015-07-31

Family

ID=43649931

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201030934T SI2473172T1 (sl) 2009-09-01 2010-09-01 Bisfosfonat sestavki in postopki za zdravljenje srčne okvare

Country Status (12)

Country Link
US (2) US9867838B2 (sl)
EP (1) EP2473172B1 (sl)
CN (2) CN105920023A (sl)
DK (1) DK2473172T3 (sl)
ES (1) ES2537216T3 (sl)
HR (1) HRP20150496T1 (sl)
HU (1) HUE025737T2 (sl)
PL (1) PL2473172T3 (sl)
PT (1) PT2473172E (sl)
SI (1) SI2473172T1 (sl)
SM (1) SMT201500124B (sl)
WO (1) WO2011028737A2 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
WO2013074587A1 (en) * 2011-11-16 2013-05-23 Duke University Bishophonate compositions and methods for treating and/or reducing cardiac dysfunction
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
US20230149430A1 (en) * 2020-04-06 2023-05-18 Duke University Compositions and methods for the treatment of infection-induced cardiomyopathy

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
DE3428524A1 (de) 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4639338A (en) 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
EP0243173B1 (en) 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
DE3623397A1 (de) 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0275821B1 (de) 1986-11-21 1992-02-26 Ciba-Geigy Ag Neue substituierte Alkandiphosphonsäuren
US5057505A (en) 1986-11-21 1991-10-15 Ciba-Geigy Corporation Substituted aminomethanediphosphonic acids and use in medicaments
GB8808138D0 (en) 1988-04-07 1988-05-11 Leo Pharm Prod Ltd Chemical compounds
JPH06500112A (ja) * 1990-08-21 1994-01-06 ジ・アップジョン・カンパニー 抗関節炎剤としてのビスホスホン酸誘導体
US5157027A (en) 1991-05-13 1992-10-20 E. R. Squibb & Sons, Inc. Bisphosphonate squalene synthetase inhibitors and method
JPH07502012A (ja) 1991-05-28 1995-03-02 ザ、プロクター、エンド、ギャンブル、カンパニー カルシウム、微量ミネラル、ビタミンｄ及び薬物療法剤組合せ
EP0600834A1 (en) 1992-11-30 1994-06-08 Ciba-Geigy Ag Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing
AU670337B2 (en) 1992-11-30 1996-07-11 Novartis Ag Use of certain methanebisphosphonic acid derivatives in fracture healing
US5403829A (en) 1993-03-24 1995-04-04 Leiras Oy Use of bisphosphonates in endo-osteal bone surgery
FI92465C (fi) 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5646134A (en) 1994-04-21 1997-07-08 Merck & Co., Inc. Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices
GB9408775D0 (en) 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
US6117856A (en) 1996-02-14 2000-09-12 Binderman; Itzhak Topical bisphosphonates for prevention of bone resorption
DE19738005A1 (de) * 1997-08-30 1999-03-04 Bayer Ag Verwendung von substituierten 1,1-Bisphosphonaten
AU760703B2 (en) 1998-01-29 2003-05-22 Merck & Co., Inc. Methods of identifying modulators of kinases responsive to stress
US6984400B2 (en) 1998-07-14 2006-01-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating restenosis using bisphosphonate nanoparticles
WO2001049295A1 (en) 2000-01-04 2001-07-12 The Regents Of The University Of California Use of low dosage bisphosphonates to inhibit cardiac and arterial calcification
WO2001064207A2 (en) * 2000-03-01 2001-09-07 University Of South Florida Methods of modulating cell-adhesion mediated drug resistance
GB0012209D0 (en) 2000-05-19 2000-07-12 Novartis Ag Organic compounds
CZ301972B6 (cs) 2000-06-20 2010-08-18 Novartis Ag Farmaceutické prostredky s obsahem kyseliny zoledronové pro lécení stavu s abnormálne zvýšeným kostním obratem
IL158273A0 (en) * 2001-05-02 2004-05-12 Novartis Ag Use of bisphosphonates in the treatment of bone metastasis associated with prostate cancer
US20030064965A1 (en) 2001-10-02 2003-04-03 Jacob Richter Method of delivering drugs to a tissue using drug-coated medical devices
AU2003226148A1 (en) 2002-04-05 2003-10-27 Merck & Co., Inc. Method for inhibiting bone resorption with an alendronate and vitamin d formulation
WO2003094851A2 (en) 2002-05-11 2003-11-20 Ilex Products, Inc. 1,1- and 1,2-bisphosphonates as apoliprotein e modulators
US20050026871A1 (en) 2002-07-17 2005-02-03 Moshe Flashner-Barak Method of increasing bioavailability of alendronate or other bis-phosphonate by predose administration of vitamin D derivative
CA2497353C (en) * 2002-09-16 2012-08-28 Novartis Ag Method for preventing or reducing secondary fractures after hip fracture
WO2004035060A1 (en) 2002-10-15 2004-04-29 Novartis Ag Bisphosphonates for the treatment of antheroscleorosis and devices comprising them
DE60330187D1 (de) * 2002-12-30 2009-12-31 Celgene Corp Fluoralkoxy-substituierte 1, 3-dihydro-isoindolyl-verbindungen und ihre pharmazeutischen verwendungen
US10517883B2 (en) 2003-06-27 2019-12-31 Zuli Holdings Ltd. Method of treating acute myocardial infarction
AU2004253527B2 (en) 2003-06-27 2010-04-08 Zuli Holdings Ltd. Method of treating acute coronary syndromes
US20060051407A1 (en) 2003-06-27 2006-03-09 Yoram Richter Method of treating ischemia-reperfusion injury
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
NZ545804A (en) 2003-09-19 2009-09-25 Wisconsin Alumni Res Found Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-or-vitamin D derivatives and a bisphosphonate
GB0327742D0 (en) * 2003-11-28 2003-12-31 Isis Innovation Novel uses of known drugs
WO2006019843A1 (en) 2004-07-15 2006-02-23 Nanobac Life Sciences Methods and compositions for the administration of calcium chelators, bisphosphonates and/or citrate compounds and their pharmaceutical uses
US20060069068A1 (en) 2004-07-15 2006-03-30 Nanobac Pharmaceuticals, Inc. Methods and compositions for the treatment of diseases characterized by pathological calcification
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
US7704977B2 (en) * 2006-04-07 2010-04-27 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
EP1925621A1 (en) * 2006-11-27 2008-05-28 Novartis AG Crystalline forms of zoledronic acid
US20080146489A1 (en) 2006-12-15 2008-06-19 Pacetti Stephen D Regional delivery of therapeutic agents for the treatment of vascular diseases
US20100144679A1 (en) 2007-03-21 2010-06-10 Duke University Medication kits and formulations for preventing, treating or reducing secondary fractures after previous fracture
BRPI0821090B8 (pt) 2007-12-21 2021-05-25 Ligand Pharm Inc moduladores seletivos de receptores de androgênio (sarms) e uso do mesmo
CN101259133A (zh) * 2008-03-28 2008-09-10 王洪 唑来磷酸用于制备预防及治疗骨质疏松症的药物
US20110112053A1 (en) 2008-04-16 2011-05-12 University Of Utah Research Foundation Pharmacological targeting of vascular malformations

Also Published As

Publication number Publication date
DK2473172T3 (en) 2015-06-15
WO2011028737A3 (en) 2011-07-14
EP2473172A2 (en) 2012-07-11
WO2011028737A2 (en) 2011-03-10
HUE025737T2 (en) 2016-05-30
US9867838B2 (en) 2018-01-16
SMT201500124B (it) 2015-07-09
US20180125869A1 (en) 2018-05-10
ES2537216T3 (es) 2015-06-03
HRP20150496T1 (hr) 2015-08-14
EP2473172A4 (en) 2013-01-16
PL2473172T3 (pl) 2015-08-31
CN102639137A (zh) 2012-08-15
PT2473172E (pt) 2015-06-25
EP2473172B1 (en) 2015-04-08
CN105920023A (zh) 2016-09-07
US20120208786A1 (en) 2012-08-16
WO2011028737A8 (en) 2012-05-18

Similar Documents

Publication Publication Date Title
HK1247820A1 (zh) 預防或治療代謝綜合症的方法
HK1217293A1 (zh) 預防或治療心力衰竭的方法
HK1206651A1 (en) Implant for tissue engineering
IL215975A (en) Heart failure device
EP2440209A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF HEART FAILURE
EP2766390A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEART ERRORS
IL239918A0 (en) Preparations for the treatment of colitis
EP2554175A4 (en) COMPOSITION FOR THE TREATMENT OF A DESIRED PART
EP2538988A4 (en) METHOD FOR TISSUE-DECELULARIZATION
EP2542060A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES
PL2808024T3 (pl) Bifidobakterie do leczenia zastoinowej niewydolności serca
EP2575669A4 (en) SUPPORTED DENTAL IMPLANT TREATMENT
EP2429584A4 (en) TREATMENT PROCEDURE AND COMPOSITIONS
EP2504428A4 (en) METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING
IL210097A0 (en) Compositions and methods for treating unfluenza
EP2575855A4 (en) METHOD FOR TREATING OR PREVENTING VASCULAR GRAFT BREAKAGE
EP2440236A4 (en) METHODS FOR TREATING HEART FAILURE BASED ON NEUREGULIN
IL215932A0 (en) Compositions and methods for treating burns
IL217492A0 (en) Treatment method
PL2473172T3 (pl) Kompozycje bisfosfonianowe i sposoby do leczenia niewydolności serca
SG10201408508YA (en) Combination composition useful for treating cardiovascular diseases
EP2485853A4 (en) TREATMENT OF FLOORS
GB0900599D0 (en) Treatment
PL2263454T3 (pl) Kompozycja uzdatniająca
EP2393506A4 (en) METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES